In light of the rapidly evolving treatment landscape for neuromuscular diseases, we would like to discuss with you this year the possibilities we have and challenges we face measuring the outcome of our patients that benefit from such therapies.
Colleagues from different medical specialities, professions, and also other Swiss reference centers have accepted to share their knowledge.
